CVS Health Enterprise Value over EBITDA Trend |
| CVS Health Corporation -- USA Stock | USD 65.12 0.74 1.12% |
This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 5.6 B, Cost of Revenue of 145 B or Earning Before Interest and Taxes EBIT of 10.1 B, but also many exotic indicators such as Interest Coverage of 11.0805, Long Term Debt to Equity of 0.7377 or Calculated Tax Rate of 40.8966. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.
Showing smoothed Enterprise Value over EBITDA of CVS Health Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earnings Before Interest Taxes and Depreciation Amortization USD.
| Enterprise Value over EBITDA | 10 Years Trend |
| Compare to Other EquitiesAll Fundamental Data |
Regression Statistics
| Arithmetic Mean | 9.06 |
| Geometric Mean | 8.89 |
| Coefficient Of Variation | 20.61 |
| Mean Deviation | 1.55 |
| Median | 8.93 |
| Standard Deviation | 1.87 |
| Sample Variance | 3.48 |
| Range | 5.07 |
| R Value | 0.41 |
| Mean Square Error | 3.17 |
| R Squared | 0.17 |
| Significance | 0.17 |
| Slope | 0.20 |
| Total Sum of Squares | 41.81 |
CVS Health Enterprise Value over EBITDA Over Time
Other Fundumenentals
My Equities
My Current Equities and Potential Positions
Thematic Opportunities
Explore Investment Opportunities
Check also analysis of CVS Health Correlation with competitors. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.